Patents by Inventor Mohamed TOUAIBIA

Mohamed TOUAIBIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY
    Publication number: 20230391711
    Abstract: The present invention relates to modulators of lipoxygenase and/or cyclooxygenase enzyme. The present invention also provides compositions comprising such modulators, and methods therewith for treating lipoxygenase receptor mediated diseases.
    Type: Application
    Filed: August 17, 2023
    Publication date: December 7, 2023
    Inventors: Mohamed Touaibia, Marc Edgar Surette
  • Modulators of lipoxygenase and cyclooxygenase enzyme activity
    Patent number: 11760715
    Abstract: The present invention relates to modulators of lipoxygenase and/or cyclooxygenase enzyme. The present invention also provides compositions comprising such modulators, and methods therewith for treating lipoxygenase receptor mediated diseases.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: September 19, 2023
    Assignee: Université de Moncton
    Inventors: Mohamed Touaibia, Marc Edgar Surette
  • COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH
    Publication number: 20220211653
    Abstract: Methods, compositions and uses for inhibiting the growth in blood cancer cells in a patient with one or more of a caffeic acid phenpropyl ester (GL8) analogue selected from the group consisting of As26, J229, J91, LL27, LL23, HM7, As25, MT26, and J205. The blood cancer cells can be myeloma, lymphoma and leukemia cells. The methods, compositions and uses can be in conjunction with the use of an IMiD to treat a patient. The compositions can include a pharmaceutically acceptable carrier, adjuvant or vehicle, a pharmaceutically acceptable salt or dietary supplement.
    Type: Application
    Filed: April 20, 2020
    Publication date: July 7, 2022
    Inventors: Alli Murugesan, Anthony Reiman, Mohamed Touaibia
  • COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH
    Publication number: 20200268700
    Abstract: Methods, compositions and uses for inhibiting the growth in blood cancer cells with one or more of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester (CAPE), CAPE analogue MT30, and CAPE analogue GL8. The blood cancer cells can be myeloma, lymphoma and leukemia cells. The methods, compositions and uses can be in conjunction with the use of an IMiD to treat a patient. The compositions can include a pharmaceutically acceptable carrier, adjuvant or vehicle, a pharmaceutically acceptable salt or dietary supplement.
    Type: Application
    Filed: October 22, 2018
    Publication date: August 27, 2020
    Inventors: Alli Murugesan, Anthony Reiman, Mohamed Touaibia
  • MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY
    Publication number: 20190119194
    Abstract: The present invention relates to modulators of lipoxygenase and/or cyclooxygenase enzyme. The present invention also provides compositions comprising such modulators, and methods therewith for treating lipoxygenase receptor mediated diseases.
    Type: Application
    Filed: March 3, 2017
    Publication date: April 25, 2019
    Applicant: Universite de Moncton
    Inventors: Mohamed TOUAIBIA, Marc Edgar SURETTE